Zhejiang NHU Co.,Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang NHU Co.,Ltd with three other
companies in this sector in China:
China Resources Double-Crane Pharmaceutical Company Limited
sales of 5.14 billion Chinese Renmimbi [US$749.30 million]
of which 52%
Shandong Xinhua Pharmaceutical Company Limited
(3.60 billion Chinese Renmimbi [US$524.67 million]
of which 46%
was Preparations), and
Apeloa Pharmaceutical Co Ltd
(4.34 billion Chinese Renmimbi [US$632.71 million]
of which 100%
was Health Care & Pharmaceutical).
Zhejiang NHU Co.,Ltd reported sales of 3.82 billion Chinese Renmimbi (US$556.91 million)
December of 2015.
decrease of 8.2%
versus 2014, when the company's sales were 4.16 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 10.6% decline
in Pharmaceutical Chemicals, from 4.06 billion Chinese Renmimbi to 3.63 billion Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Other, Main Operation (up 140.5% to 166.15 million Chinese Renmimbi)